Pfizer hiked its projections for COVID vaccine revenues, telling investors this week it expects booster shots, a vaccine targeting the Delta variant and anticipated authorization of its vaccines for children as young as 6 months will drive revenues higher.
A Wall Street Journal op-ed claims the FDA is "attacking a safe, effective drug," Ivermectin, even though the FDA itself certified the medication in 1996.
Pfizer met with U.S. regulators Monday evening to press its case for quick authorization of COVID booster vaccines but health officials, who remained unconvinced, called for more data.
U.S. Food and Drug Administration (FDA) expected to warn about link between Johnson & Johnson Covid-19 vaccine and cases of a rare neurological disorder associated with other shots.
U.S. federal health agencies and the maker of one of the most popular COVID vaccines are publicly at odds over whether fully vaccinated people will soon need a third booster shot.
During an FDA meeting Thursday to discuss granting Emergency Use Authorization for COVID vaccines for children under 12, several experts spoke out against the plan, saying the benefits don’t outweigh the risks for young children.
As they say, the proof is in the pudding. COVID-19 shots have been the deadliest inoculations ever documented, by far, and that’s according to the CDC’s very own data.
